Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q39651272)
Watch
English
Selection of Streptococcus pneumoniae mutants having reduced susceptibility to moxifloxacin and levofloxacin.
scientific article published on February 2002
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMCID
127057
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11796368%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 December 2019
title
Selection of Streptococcus pneumoniae mutants having reduced susceptibility to moxifloxacin and levofloxacin
(English)
1 reference
stated in
Europe PubMed Central
PMCID
127057
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11796368%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 December 2019
main subject
Streptococcus pneumoniae
1 reference
based on heuristic
inferred from title
moxifloxacin
1 reference
based on heuristic
inferred from title
author
Xilin Zhao
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMCID
127057
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11796368%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 December 2019
author name string
Xinying Li
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMCID
127057
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11796368%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 December 2019
Karl Drlica
series ordinal
3
1 reference
stated in
Europe PubMed Central
PMCID
127057
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11796368%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 December 2019
language of work or name
English
0 references
publication date
1 February 2002
1 reference
stated in
Europe PubMed Central
PMCID
127057
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11796368%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 December 2019
published in
Antimicrobial Agents and Chemotherapy
1 reference
stated in
Europe PubMed Central
PMCID
127057
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11796368%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 December 2019
volume
46
1 reference
stated in
Europe PubMed Central
PMCID
127057
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11796368%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 December 2019
issue
2
1 reference
stated in
Europe PubMed Central
PMCID
127057
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11796368%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 December 2019
page(s)
522-524
1 reference
stated in
Europe PubMed Central
PMCID
127057
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11796368%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 December 2019
cites work
Enhancement of fluoroquinolone activity by C-8 halogen and methoxy moieties: action against a gyrase resistance mutant of Mycobacterium smegmatis and a gyrase-topoisomerase IV double mutant of Staphylococcus aureus
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127057
retrieved
14 September 2017
Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127057
retrieved
14 September 2017
Fluoroquinolone-resistant Streptococcus pneumoniae associated with levofloxacin therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127057
retrieved
14 September 2017
Contributions of the 8-methoxy group of gatifloxacin to resistance selectivity, target preference, and antibacterial activity against Streptococcus pneumoniae
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127057
retrieved
14 September 2017
Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127057
retrieved
14 September 2017
Mutant prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127057
retrieved
14 September 2017
Intracellular targets of moxifloxacin: a comparison with other fluoroquinolones
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127057
retrieved
14 September 2017
Gatifloxacin activity against quinolone-resistant gyrase: allele-specific enhancement of bacteriostatic and bactericidal activities by the C-8-methoxy group
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127057
retrieved
14 September 2017
Pharmacokinetics of a once-daily oral dose of moxifloxacin (Bay 12-8039), a new enantiomerically pure 8-methoxy quinolone
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127057
retrieved
14 September 2017
Contribution of topoisomerase IV and DNA gyrase mutations in Streptococcus pneumoniae to resistance to novel fluoroquinolones
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127057
retrieved
14 September 2017
Effect of fluoroquinolone concentration on selection of resistant mutants of Mycobacterium bovis BCG and Staphylococcus aureus
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127057
retrieved
14 September 2017
Fluoroquinolone action against clinical isolates of Mycobacterium tuberculosis: effects of a C-8 methoxyl group on survival in liquid media and in human macrophages
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127057
retrieved
14 September 2017
Fluoroquinolone action against mycobacteria: effects of C-8 substituents on growth, survival, and resistance
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127057
retrieved
14 September 2017
Prevalence of a putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127057
retrieved
14 September 2017
Killing of Staphylococcus aureus by C-8-methoxy fluoroquinolones
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127057
retrieved
14 September 2017
Double-blind evaluation of the safety and pharmacokinetics of multiple oral once-daily 750-milligram and 1-gram doses of levofloxacin in healthy volunteers
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127057
retrieved
14 September 2017
DNA topoisomerase targets of the fluoroquinolones: a strategy for avoiding bacterial resistance
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127057
retrieved
14 September 2017
Contribution of the C-8 substituent of DU-6859a, a new potent fluoroquinolone, to its activity against DNA gyrase mutants of Pseudomonas aeruginosa
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127057
retrieved
14 September 2017
Escherichia coli K-12 Mutants Resistant to Nalidixic Acid: Genetic Mapping and Dominance Studies
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127057
retrieved
14 September 2017
Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127057
retrieved
14 September 2017
Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127057
retrieved
14 September 2017
Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127057
retrieved
21 August 2018
The mechanism of inhibition of topoisomerase IV by quinolone antibacterials
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127057
retrieved
21 August 2018
Identifiers
DOI
10.1128/AAC.46.2.522-524.2002
1 reference
stated in
Europe PubMed Central
PMCID
127057
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11796368%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 December 2019
PMCID
127057
1 reference
stated in
Europe PubMed Central
PMCID
127057
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11796368%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 December 2019
PubMed ID
11796368
1 reference
stated in
Europe PubMed Central
PMCID
127057
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11796368%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 December 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
